Behcet's Disease
Get diagnosed, get treated, get your life back!
The ABDA's mission focuses on empowering our diverse community. Inclusion is how we unleash the power of diversity. We model a spirit of equity, respect, inclusion, and cooperation in all our actions.
The American Behcet's Disease Association advocates for policies affecting the lives of patients and their families. Our efforts aim to affect change, actively work on proposals to protect and improve key policies at local, state and federal levels and ultimately improve patient outcomes and quality of life. Addressing issues such as access to care, treatment innovations, research and healthcare policies, the voice of those affected by Behcet's Disease and rare diseases is of utmost importance.
Join us at the Autoimmune Summit on October 15-16, 2021. Registration for this online event is free. Register at: https://whova.com/web/autoi_202104/
Coronavirus (COVID-19) Updates
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a single booster shot of the Pfizer-BioNTech COVID-19 vaccine. Certain populations are now eligible to receive a booster shot of the Pfizer-BioNTech vaccine at least 6 months after receiving the second Pfizer-BioNTech shot. These populations include people ages 65 years and older, people ages 18 years and older who have underlying medical conditions, and people ages 18 years and older who live or work in high-risk settings.
CDC https://www.cdc.gov/coronavirus/2019-ncov/
NIH https://www.nih.gov/health-information/coronavirus
FDA https://www.fda.gov/…/mcm…/coronavirus-disease-2019-covid-19
WHO https://www.who.int/health-topics/coronavirus
The ABDA's mission focuses on empowering our diverse community. Inclusion is how we unleash the power of diversity. We model a spirit of equity, respect, inclusion, and cooperation in all our actions.
The American Behcet's Disease Association advocates for policies affecting the lives of patients and their families. Our efforts aim to affect change, actively work on proposals to protect and improve key policies at local, state and federal levels and ultimately improve patient outcomes and quality of life. Addressing issues such as access to care, treatment innovations, research and healthcare policies, the voice of those affected by Behcet's Disease and rare diseases is of utmost importance.
Join us at Autoimmune Summit. Registration for this online event is free. Register at https://whova.com/web/autoi_202104/
Coronavirus (COVID-19)
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a single booster shot of the Pfizer-BioNTech COVID-19 vaccine. Certain populations are now eligible to receive a booster shot of the Pfizer-BioNTech vaccine at least 6 months after receiving the second Pfizer-BioNTech shot. These populations include people ages 65 years and older, people ages 18 years and older who have underlying medical conditions, and people ages 18 years and older who live or work in high-risk settings.
CDC https://www.cdc.gov/coronavirus/2019-ncov/
NIH https://www.nih.gov/health-information/coronavirus
FDA https://www.fda.gov/…/mcm…/coronavirus-disease-2019-covid-19
WHO https://www.who.int/health-topics/coronavirus
ASSISTANCE AND RESOURCES
WAYS TO HELP
Order Awareness Bracelets
Donate to the ABDA and receive free bracelets!
Become a Member
Becoming a member will provide recognition as a reliable contributor to the ABDA's advocacy and educational effort.
EVENTS
Patient Education Program & Walk for Behcet's Disease
As the outbreak of COVID-19 has been developing worldwide, ABDA has been closely tracking its impact on the global community. The Patient Education Program & Walk for Behcet's Disease have been postponed until next year. Our free educational webinars are planned for 2021. Please stay tuned.
Thank you for your constant support!
-The ABDA Board and Staff.
